Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

NCT ID: NCT01460082

Last Updated: 2014-03-12

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 29 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2008-08-31
• Study Completion Date: 2010-09-30

Brief Summary

The purpose of the study is to determine a possible association between the clinical entity of exacerbation, markers of systemic inflammation and endothelial dysfunction in patients with COPD.

Detailed Description

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the lungs; however, there is cumulating data suggesting that the inflammatory reaction associated with COPD is not restricted to the lungs but has systemic effects. Patients with COPD have increased cardiovascular morbidity and mortality. The suspected link between increased cardiovascular mortality and systemic inflammation is endothelial dysfunction, which in turn is caused by impaired activity of NO. Endothelial dysfunction has been demonstrated in patients with COPD. Furthermore there is a close correlation between endothelial dysfunction in coronary and peripheral vessels, which allows assessing flow-mediated dilation (FMD) in the brachial artery via high resolution ultrasound as an early predictor of atherosclerosis. Moreover, systemic inflammatory markers correlate with endothelial dysfunction in patients with stable COPD.

Exacerbations of COPD are episodes of worsening symptoms characterized by increased airway and systemic inflammation. If systemic inflammation is a cause of endothelial dysfunction in COPD, endothelial function would be suspected to be further impaired during exacerbation and recover thereafter. The purpose of this study is to determine a possible association between the clinical entity of exacerbation, markers of systemic inflammation and endothelial dysfunction in patients with COPD.

Conditions

Chronic Obstructive Pulmonary Disease (COPD); Inflammatory Disease; Endothelial Dysfunction

Study Design

• Observational Model Type: CASE_ONLY
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Exacerbation

The study sample will consist of patients admitted to the hospital because of an acute exacerbation of COPD

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• presence of COPD according to standard criteria
• acute exacerbation of COPD according to recommended international criteria
• over 40 years of age
• history of at least 10 py

Exclusion Criteria

• pneumonia
• history or signs of congestive heart failure,
• acute myocardial infarction
• thoracotomy incl. resection of lungtissue
• interstitial lung disease
• acute or chronic renal failure
• active malignancy
• autoimmune disease

• Minimum Eligible Age: 40 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology

NETWORK

Sponsor Role: lead

Responsible Party

Matthias Urban

M.D., Study coordinator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Georg C Funk, M.D.

Role: PRINCIPAL_INVESTIGATOR

1. Department of Respiratory and Critical Care Medicine and Ludwig Boltzmann Institute for COPD, Otto-Wagner Hospital, Vienna, Austria

Locations

1.Department of Respiratory and Critical Care Medicine and Ludwig Boltzmann Institute for COPD, Otto-Wagner Hospital

Vienna, Vienna, Austria

Countries

Austria

Other Identifiers

EDAECOPD

Identifier Type: -

Identifier Source: org_study_id